Effect of losartan on early liver fibrosis development in a rat model of nonalcoholic steatohepatitis
✍ Scribed by Patricio Ibañez; Nancy Solis; Margarita Pizarro; Gloria Aguayo; Ignacio Duarte; Juan Francisco Miquel; Luigi Accatino; Marco Arrese
- Book ID
- 108951161
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 317 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0815-9319
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Silymarin (SIL), a standardized plant extract containing about 60% of the polyphenol silibinin, is used as a hepatoprotective agent. In order to explore the effect of SIL on liver cell regeneration in a model of progressive biliary liver fibrosis this substance was applied to adult Wistar rats that
which may be modulated by the most potent fibrogenic cyto-Hepatic fibrosis, which may lead to cirrhosis, is associkine, transforming growth factor b 1 (TGF-b 1 ). 5,6 Hepatic fiated with most chronic liver diseases. Current therapies brosis is associated with an activation of lipocytes. 2 In hepatic
The continuous intragastric in vivo enteral feeding model in the rat developed by Tsukamoto and French has been very useful; however, it requires surgical expertise. Recently, we found that Kupffer cells isolated from rats treated only once with ethanol were sensitized to endotoxin 24 hours later. A
Liver fibrosis is characterized by increased synthesis, and decreased degradation, of extracellular matrix (ECM) within the injured tissue. Decreased ECM degradation results, in part, from increased expression of tissue inhibitor of metalloproteinase-1 (TIMP-1), which blocks matrix metalloproteinase